March 10, 2022 | Gil Blander, Impetus Digital, InsideTracker, Natalie Yeadon, aging, artificial intelligence, big data, biomarkers, blood biometrics, continuous glucose monitoring, longevity, personalized health
Dr. Gil Blander, Co-founder & Chief Scientific Officer at InsideTracker, explores consumer-driven healthcare, the use of big data and AI for creating personalized health protocols, the trillion-dollar “longevity economy,” and how approaches like blood biometric-based aging and longevity analysis play into the longevity market.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person.
At Impetus Digital, the health and wellbeing of our staff, clients, advisors, and their families is always our top priority. Recently, we have seen high numbers of advisors cancel their…
Impetus Digital shares its Top 10 list of the most important advisor questions.
Our online solutions are not just for advisory boards – find out how one client leveraged the Impetus InSite Platform® for a virtual journal club.
